Related Experiment Videos
[Impulse cytophotometric studies on DNA in bladder carcinoma]
Onkologie
|December 1, 1980
Summary
Quantitative cellular DNA estimations using flow cytometry reveal distinct ploidy patterns in bladder tumors. Aneuploid tumors, particularly those deviating from tetraploidy, show increased malignancy and proliferation.
Area of Science:
- Oncology
- Cell Biology
- Biotechnology
Context:
- Quantitative cellular DNA estimation using rapid-flow cytofluorometry is crucial for diagnosing and treating bladder cancer.
- Understanding tumor ploidy and proliferation is key to assessing malignancy and therapeutic outcomes.
Purpose:
- To evaluate the significance of quantitative cellular DNA estimations in newly diagnosed bladder tumors and carcinoma in situ.
- To correlate DNA ploidy patterns and S-phase cell proportions with tumor grade, malignancy, and treatment response.
Summary:
- Flow cytometry-based DNA estimations reveal that most T1 bladder tumors and carcinoma in situ are aneuploid, while Grade 1 tumors are diploid.
- Tumor malignancy increases with deviation from tetraploidy among aneuploid tumors, correlated with higher S-phase cell counts.
- DNA content analysis provides objective assessment of therapeutic efficacy for carcinoma in situ treated with adriamycine.
Impact:
- Establishes DNA ploidy analysis as a valuable tool for bladder cancer prognostication and treatment monitoring.
- Highlights the prognostic significance of aneuploidy and deviation from tetraploidy in bladder tumors.
- Demonstrates the utility of flow cytometry in assessing treatment response for carcinoma in situ.